apotex semaglutide Receives FDA Tentative Approval for Injection | Struan Keir, MBA posted on the topic The FDA approves Apotex Corp.'s

WARNING THIS PRODUCT IS ONLY IN

This article del...

As weight-loss drug popularity soars, more benefits and risks of the drugs are emerging.

Nevertheless, bone consequences of intentional weight loss interventions in PwO are well known: (i) significant weight loss induced by caloric restriction and bariatric surgery results in accelerated bone turnover and bone loss, and (ii) unlike caloric restriction interventions, PwO experience a substantial deterioration in bone microarchitecture and strength associated with an increased risk of fracture after bariatric surgery especially malabsorptive procedures

Reddy's renames its semaglutide drug to 'Olymra' after a court ruling, facing a crowded Indian market with generics, price wars, and strict regulatory oversight.